- |||||||||| AZD8076 / AstraZeneca, Inovio, AZD5396 / Inovio, AstraZeneca
Enrollment open, Enrollment change, Trial completion date, Trial primary completion date: dMAbs for Prevention of COVID-19 (clinicaltrials.gov) - Sep 21, 2023
P1, N=39, Recruiting,
Active, not recruiting --> Recruiting | N=26 --> 39 | Trial completion date: Sep 2024 --> Sep 2025 | Trial primary completion date: Sep 2024 --> Sep 2025
- |||||||||| AZD8076 / AstraZeneca, Inovio, AZD5396 / Inovio, AstraZeneca
Enrollment closed, Trial completion date, Trial primary completion date: dMAbs for Prevention of COVID-19 (clinicaltrials.gov) - Apr 21, 2023
P1, N=26, Active, not recruiting,
Active, not recruiting --> Recruiting | N=26 --> 39 | Trial completion date: Sep 2024 --> Sep 2025 | Trial primary completion date: Sep 2024 --> Sep 2025 Recruiting --> Active, not recruiting | Trial completion date: Nov 2023 --> Sep 2024 | Trial primary completion date: Nov 2023 --> Sep 2024
- |||||||||| AZD8076 / AstraZeneca, Inovio, AZD5396 / Inovio, AstraZeneca
Enrollment open, Enrollment change, Trial completion date, Trial primary completion date: dMAbs for Prevention of COVID-19 (clinicaltrials.gov) - Jun 1, 2022
P1, N=24, Recruiting,
Recruiting --> Active, not recruiting | Trial completion date: Nov 2023 --> Sep 2024 | Trial primary completion date: Nov 2023 --> Sep 2024 Not yet recruiting --> Recruiting | N=18 --> 24 | Trial completion date: May 2023 --> Nov 2023 | Trial primary completion date: May 2023 --> Nov 2023
- |||||||||| AZD8076 / AstraZeneca, Inovio, AZD5396 / Inovio, AstraZeneca
New P1 trial: dMAbs for Prevention of COVID-19 (clinicaltrials.gov) - Mar 23, 2022
P1, N=18, Not yet recruiting,
|
